Hepatitis B



Hepatitis B Prevalence in the Turkish Population Living in Middle Limburg


Condition:   Hepatitis B
Interventions:   Diagnostic Test: Hepatitis B serology;   Other: Questionnaire
Sponsor:   Hasselt University
Recruiting


Immunogenicity of Hepatitis B Vaccination in HIV-infected Adults


Condition:   Hepatitis B Vaccine
Interventions:   Biological: 60 µg dose hepatitis B vaccine;   Biological: 20 µg dose hepatitis B vaccine
Sponsors:   Suping Wang;   Centers for Disease Control and Prevention, China
Active, not recruiting


Ledipasvir/Sofosbuvir for Hepatitis B Virus Infection


Condition:   Hepatitis B
Intervention:   Drug: Ledipasvir-Sofosbuvir
Sponsors:   University of Maryland;   Gilead Sciences;   KlinEra Global Services
Not yet recruiting


Hepatitis B Reactivation During Treatment With Direct-Acting Antiviral Agents for Chronic Hepatitis C Infection


Condition:   Hepatitis B
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrolling by invitation


Immunologic Response of Hepatitis B Vaccine


Condition:   Hepatitis B
Intervention:   Biological: Hepatitis B vaccine
Sponsor:   Chiang Mai University
Recruiting


Clinical and Basic Research of ETV Plus GM-CSF in Chronic Hepatitis B Patients


Condition:   Hepatitis B, Chronic
Interventions:   Drug: Granulocyte Macrophage-colony Stimulating Factor;   Drug: Entecavir
Sponsor:   Beijing 302 Hospital
Recruiting


A Nation-wide Hospital-based Hepatitis B Registry:China Registry of Hepatitis B


Condition:   Chronic Hepatitis B
Intervention:  
Sponsors:   Beijing Friendship Hospital;   Beijing YouAn Hospital;   First Hospital of Jilin University;   Henan Provincial Hospital;   Beijing Ditan Hospital;   First Affiliated Hospital of Xinjiang Medical University;   LanZhou University;   The Second Affiliated Hospital of Chongqing Medical University;   West China Hospital;   Taiyuan No.3 Hospital;   Hebei Medical University Third Hospital;   Shengjing Hospital;   Tianjin Third Central Hospital;   Peking University First Hospital;   Peking Union Medical College Hospital;   The Affiliated Hospital Of Southwest Medical University;   Shanghai Public Health Clinical Center;   Ruijin Hospital;   First Affiliated Hospital Xi'an Jiaotong University;   Xiangya Hospital of Central South University;   Beijing Tiantan Hospital,Capital Medical University;   Wuhan University;   The First Affiliated Hospital of Kunming Medical College;   The Affiliated Hospital of Xuzhou Medical University;   The Affiliated Hospital of Yanbian University;   First Affiliated Hospital of Chongqing Medical University;   The Fouth Hospital of Qinghai province;   Affiliated Hospital of Weifang Medical University;   Hunan Provincial People's Hospital;   The Second Hospital of Hebei Medical University;   Xixi Hospital of Hangzhou;   General Hospital of Ningxia Medical University;   Union Hospital,Tong Ji Medical College,Huazhong University of Science and Technology;   Xinjiang Uygur Autonomous Region Traditional Chinese Medicine Hospital;   Peking University People's Hospital;   Nanfang Hospital of Southern Medical University;   The Affiliated Hospital Of Guizhou Medical University;   Guizhou Provincial People's Hospital;   Hainan General Hospital;   The Second Hospital of Shandong University;   The First Affiliated Hospital of Shanxi Medical University;   Fifth Hospital of Shijiazhuang City;   Yan'an University Affiliated Hospital;   Infectious Disease Hospital of Wuhai;   Affiliated Hospital, Logistics University of People's Armed Police Force;   People's Hospital of Changji Hui Autonomous Prefecture,Xinjiang
Recruiting


Tenofovir in Early Pregnancy to Prevent Mother-to-child Transmission of Hepatitis B Virus


Condition:   Hepatitis B
Intervention:   Drug: Tenofovir Disoproxil Fumarate
Sponsors:   Johns Hopkins Bloomberg School of Public Health;   Thrasher Research Fund;   Shoklo Malaria Research Unit;   Chiang Mai University;   University of Oxford
Not yet recruiting


TAF Switch Study in Hepatitis B Monoinfection


Condition:   Hepatitis B
Intervention:   Drug: Tenofovir alafenamide fumarate
Sponsor:   Asian Pacific Liver Center at St. Vincent Medical Center
Active, not recruiting


Long-term Persistence of Immunity to Hepatitis B in Adults Vaccinated With GlaxoSmithKline (GSK) Biologicals' Hepatitis B Vaccine (HBV), Engerix™-B


Condition:   Hepatitis B Vaccine
Intervention:   Biological: Engerix-B
Sponsor:   GlaxoSmithKline
Completed



Is Hepatitis B Surface Antigen (HB s Ag) Enough Alone as a Screening Test Before Immunosuppressive Therapies?


Condition:   Hepatitis B
Intervention:   Other: HBV core antibodies testing. • Real time PCR testing.
Sponsor:   Sherief Abd-Elsalam
Recruiting


Hepatitis B Vaccination in HIV-infected Adults With Low CD4 Cell Counts


Condition:   Hepatitis B
Intervention:   Biological: Recombinant Hepatitis B vaccine [(CIGB) La Habana, Cuba]
Sponsor:   Chiang Mai University
Completed


Combination Treatment With REP 2139-Ca and Pegasys in Patients With Chronic Hepatitis B


Condition:   Hepatitis B, Chronic
Interventions:   Drug: REP 2139-Ca;   Drug: pegylated interferon;   Drug: entecavir
Sponsor:   Replicor Inc.
Completed


Hepatitis B Vaccination in HIV-infected Adults


Condition:   Hepatitis B
Intervention:   Biological: recombinant HBV vaccine (Hepavax-Gene® Berna, Korea)
Sponsor:   Chiang Mai University
Completed


Mechanisms Associated With Favorable Responses to Peginterferon-Alpha Add-on Therapy Following Long-term Nucleos(t)Ide Analogue Treatment in Patients With Chronic Hepatitis B


Condition:   Chronic Hepatitis B
Intervention:   Drug: Peginterferon alfa-2a
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Recruiting


Safety and Efficacy Study of NVR 3-778 in Healthy Volunteers and Hepatitis B Patients


Condition:   Chronic Hepatitis B
Interventions:   Drug: NVR 3-778;   Drug: Placebo for NVR 3-778;   Drug: Pegasys
Sponsor:   Novira Therapeutics, Inc.
Completed


A Study of the Immune Response to Heplisav in Healthy Older Adults


Condition:   Hepatitis B
Intervention:   Biological: HEPLISAV
Sponsors:   Dynavax Technologies Corporation;   Baylor Research Institute
Completed


Study for Consolidation Period of Chronic Hepatitis B


Condition:   Hepatitis B
Intervention:  
Sponsor:   Tainan Municipal Hospital
Active, not recruiting


Combination Entecavir and Peginterferon Therapy in HBeAg-Positive Immune-Tolerant Adults With Chronic Hepatitis B


Condition:   Hepatitis B
Intervention:   Drug: Entecavir and peginterferon
Sponsors:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   University of Pittsburgh;   National Center for Research Resources (NCRR)
Completed


HBRN: Immune Regulation and Costimulation in Natural History of Chronic Hepatitis B


Condition:   Hepatitis B
Intervention:  
Sponsors:   University of Pennsylvania;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Active, not recruiting


Hepatitis B Research Network Pediatric Cohort Study (HBRN)


Condition:   Hepatitis B
Intervention:  
Sponsors:   University of Pittsburgh;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Active, not recruiting


Hepatitis B Research Network Adult Cohort Study


Condition:   Hepatitis B
Intervention:  
Sponsors:   University of Pittsburgh;   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK);   National Center for Research Resources (NCRR)
Recruiting


Study to Compare the Efficacy of GSK Biologicals' Adjuvants in Combination With the Antigen of the Hepatitis B Vaccine


Condition:   Hepatitis B
Interventions:   Biological: Engerix-B™;   Biological: Fendrix™;   Biological: GSK Biologicals' Hepatitis B vaccines (GSK223192A);   Biological: HBsAg (Booster injection)
Sponsor:   GlaxoSmithKline
Completed


Effectiveness of Two Hepatitis B Vaccines in HIV-negative Youths


Condition:   Hepatitis B
Interventions:   Biological: Recombivax;   Biological: Twinrix
Sponsors:   University of North Carolina, Chapel Hill;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Institute on Drug Abuse (NIDA);   National Institute of Mental Health (NIMH);   National Institute on Alcohol Abuse and Alcoholism (NIAAA)
Completed

Refine Your Search Advanced Search